Yahoo · Sep 10, 2026
Zimmer restructures Americas leadership team
The company promoted three executives and eliminated a fourth position as part of changes intended to support its ongoing commercial transformation.
NYSE · ZBH
Zimmer Biomet Holdings, Inc.
Healthcare · Medical - Devices
$98.41
Up+$1.87 (+1.94%)
Updated Sep 16, 2026, 12:03 PM
SID Score
6.2/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 18.32B
- P/E ratio
- 22.74
- Dividend yield
- 0.98%
- 52-week range
- $79.12 – $102.86
- Volume
- 3.62M
- Avg. volume
- 1.84M
Price performance
ZBH price history
1M range · 20 trading sessions · Daily adjusted prices
ZBH closed at $98.41 after 20 trading sessions, down 0.75% for the selected period.
- Last close
- $98.41
- Period change
- -0.75%
- Period low
- $92.44
- Period high
- $101.38
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $96.44 | $99.1825 | $95.87 | $98.41 | 3.62M |
| Sep 14, 2026 | $95.25 | $96.98 | $94.685 | $96.54 | 2.03M |
| Sep 11, 2026 | $92.95 | $93.64 | $91.74 | $93.49 | 1.88M |
| Sep 10, 2026 | $94.04 | $94.045 | $91.45 | $92.44 | 1.37M |
| Sep 9, 2026 | $93.02 | $95.73 | $92.55 | $94.61 | 2.07M |
| Sep 8, 2026 | $97.05 | $97.23 | $91.87 | $94.22 | 3.13M |
| Sep 4, 2026 | $97.77 | $98.765 | $96.8444 | $98.07 | 1.33M |
| Sep 3, 2026 | $100.06 | $101.81 | $98.15 | $98.92 | 1.28M |
| Sep 2, 2026 | $99.32 | $101.71 | $99.0079 | $99.50 | 1.39M |
| Sep 1, 2026 | $101.49 | $102.86 | $99.041 | $99.40 | 1.39M |
| Aug 31, 2026 | $100.20 | $100.30 | $99.53 | $100.04 | 1.3M |
| Aug 28, 2026 | $99.61 | $101.32 | $99.245 | $100.91 | 1.19M |
| Aug 27, 2026 | $99.93 | $101.28 | $99.21 | $99.48 | 1.35M |
| Aug 26, 2026 | $99.52 | $101.98 | $99.20 | $101.38 | 1.35M |
| Aug 25, 2026 | $100.14 | $100.87 | $99.28 | $100.24 | 1.27M |
| Aug 24, 2026 | $101.32 | $102.12 | $100.69 | $100.98 | 1.5M |
| Aug 21, 2026 | $98.67 | $101.15 | $98.67 | $100.98 | 1.16M |
| Aug 20, 2026 | $100.01 | $101.63 | $98.97 | $98.97 | 1.33M |
| Aug 19, 2026 | $98.72 | $101.95 | $98.09 | $100.74 | 1.5M |
| Aug 18, 2026 | $99.58 | $100.38 | $98.2701 | $99.15 | 1.21M |
Latest ZBH news
The latest Smart Investors Daily articles mentioning ZBH.
Stock researchCompany · Overview
ZBH research
Overview
Company profile and research snapshot.
Company profile
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $112.29
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 10, 2026 | Canaccord Genuity | Hold | — |
| Aug 7, 2026 | Truist Securities | Hold | — |
| Aug 6, 2026 | Bernstein | Market Perform | — |
| Aug 6, 2026 | Stifel | Buy | — |
| Aug 6, 2026 | RBC Capital | Outperform | — |
News briefing
No generated briefing is available yet.
Yahoo · Sep 8, 2026
Zimmer Biomet Announces Americas Leadership Promotions to Accelerate Commercial Transformation
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced leadership appointments designed to streamline its Americas and Global Business Group organizations for greater focus and agility.
Benzinga · Sep 8, 2026
Zimmer Biomet Reiterates Its FY 2026 Financial Outlook
Zimmer Biomet also announced today that the Company is reiterating its full-year 2026 financial outlook provided on August 5, 2026.
Yahoo · Sep 4, 2026
Why Is Zimmer (ZBH) Up 1.8% Since Last Earnings Report?
Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
